Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma.
Rini
Brian I
BI
Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA. rinib2@ccf.org
Stein
Mark
M
Shannon
Pat
P
Eddy
Simantini
S
Tyler
Allison
A
Stephenson
Joe J
JJ
Catlett
Lorie
L
Huang
Bo
B
Healey
Diane
D
Gordon
Michael
M